Dr. Daryl Rees is Chief Executive of pharmaceutical development specialists, Salupont Consulting.  He is a Clinical Pharmacologist with over 25 years experience in successful global medicines development, commercialisation and licensing.  As Chief Scientist and CEO of Phytopharm Plc., he initiated and led the development of Cogane, a potential disease modifying agent for Parkinson’s Disease and progressed this drug candidate from medicinal chemistry to Phase II clinical studies. He is external examiner for pharmaceutical medicine qualifications at Trinity College, Dublin, guest lecturer at Kings College, London on Pharmaceutical Medicine and for the last 12 years, Chair of a National Research Ethics Committee in UK.  Dr. Rees has significant experience in regulatory evaluation of clinical trials and is passionate about developing products for poorly served diseases and works closely with several charities and patient groups to promote this issue.